Email This Article
Headlines & Perspectives
Feuerstein's Biotech-Stock Mailbag: Elan
By
Adam Feuerstein
08/01/08 - 12:15 PM EDT
Revaluing a severely beaten Elan. And wanted: Your votes on best biotech CEO.
The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,286.42 | 1,088.26 | 2,126.69 | 32.18 |
Oil *
77.60
|
|
DOWN
23.50
|
DOWN
3.23
|
DOWN
11.75
|
DOWN
0.13
|
10 Yr
3.22%
SPDR Gold
115.25
|
|
-0.23%
|
-0.30%
|
-0.55%
|
-0.40%
|
Data delayed 20 minutes |


Connect with TheStreet